HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.

AbstractBACKGROUND:
Despite familial clustering of nephropathy and retinopathy severity in type 1 diabetes, few gene variants have been consistently associated with these outcomes.
RESEARCH DESIGN AND METHODS:
We performed an individual-based genetic association study with time to renal and retinal outcomes in 1,362 white probands with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Specifically, we genotyped 1,411 SNPs that capture common variations in 212 candidate genes for long-term complications and analyzed them for association with the time from DCCT baseline to event for renal and retinal outcomes using multivariate Cox proportion hazards models. To address multiple testing and assist interpretation of the results, false discovery rate q values were calculated separately for each outcome.
RESULTS:
We observed association between rs17880135 in the 3' region of superoxide dismutase 1 (SOD1) and the incidence of both severe nephropathy (hazard ratio [HR] 2.62 [95% CI 1.64-4.18], P = 5.6 x 10(-5), q = 0.06) and persistent microalbuminuria (1.82 [1.29-2.57], P = 6.4 x 10(-4), q = 0.46). Sequencing and fine-mapping identified additional SOD1 variants, including rs202446, rs9974610, and rs204732, which were also associated (P < 10(-3)) with persistent microalbuminuria, whereas rs17880135 and rs17881180 were similarly associated with the development of severe nephropathy. Attempts to replicate the findings in three cross-sectional case-control studies produced equivocal results. We observed no striking differences between risk genotypes in serum SOD activity, serum SOD1 mass, or SOD1 mRNA expression in lymphoblastoid cell lines.
CONCLUSIONS:
Multiple variations in SOD1 are significantly associated with persistent microalbuminuria and severe nephropathy in the DCCT/EDIC study.
AuthorsHussam Al-Kateb, Andrew P Boright, Lucia Mirea, Xinlei Xie, Rinku Sutradhar, Alireza Mowjoodi, Bhupinder Bharaj, Michelle Liu, Jean M Bucksa, Valerie L Arends, Michael W Steffes, Patricia A Cleary, Wanjie Sun, John M Lachin, Paul S Thorner, Michael Ho, Amy Jayne McKnight, A Peter Maxwell, David A Savage, Kenneth K Kidd, Judith R Kidd, William C Speed, Trevor J Orchard, Rachel G Miller, Lei Sun, Shelley B Bull, Andrew D Paterson, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
JournalDiabetes (Diabetes) Vol. 57 Issue 1 Pg. 218-28 (Jan 2008) ISSN: 1939-327X [Electronic] United States
PMID17914031 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Hypoglycemic Agents
  • Nuclear Proteins
  • RNA-Binding Proteins
  • SOD1 protein, human
  • Serine-Arginine Splicing Factors
  • Serine
  • Superoxide Dismutase
  • Superoxide Dismutase-1
  • Alanine
Topics
  • Alanine
  • Albuminuria (genetics)
  • Amino Acid Substitution
  • Diabetic Nephropathies (drug therapy, enzymology, genetics)
  • Diabetic Retinopathy (genetics)
  • Disease Progression
  • Genetic Variation
  • Genotype
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Nuclear Proteins (genetics)
  • Polymorphism, Single Nucleotide
  • RNA-Binding Proteins (genetics)
  • Serine
  • Serine-Arginine Splicing Factors
  • Superoxide Dismutase (genetics)
  • Superoxide Dismutase-1
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: